@FierceBiotech: $AMGN uncovers trove of gene knockouts in 'molecular national selfie.' Story | Follow @FierceBiotech
@JohnCFierce: ICYMI: Not giving up day job, but interviewing @Asthika from Bloomberg Intelligence on biotech market was fun. Watch | Follow @JohnCFierce
@DamianFierce: Sivextro v. Sovaldi. Vimizim v. Movantik. Belsomra lost?!? It's the Sweet 16 in @FiercePharma's #FierceMadness. Vote | Follow @DamianFierce
> Former Teva ($TEVA) CEO Jeremy Levin is back in biopharma, serving as chairman of upstart Ovid Therapeutics as the company pursues treatments for rare neurological diseases. More
> U.K. biotech Redx Pharma executed a £15 million ($22 million) IPO on the London exchange. Item
> Merck ($MRK) has extended its antibody R&D deal with Ablynx. Release
> The U.K.'s Biomedical Catalyst Fund is setting out another £40 million ($59 million) to support biotech projects around the country. News
Medical Device News
@FierceMedDev: ICYMI yesterday: Novartis rides med tech wave with new digital projects. Article | Follow @FierceMedDev
@EmilyWFierce: Cipla revs up for generic Sovaldi launch in India. FiercePharma story | Follow @EmilyWFierce
> J&J's DePuy inks deal with Radlink to market imaging tech with hip replacement devices. Article
> Zimmer: New outpatient program for Persona Knee patients is succeeding. Report
Pharma News
@FiercePharma: Germany's cost watchdog decides Valeant's Provenge has added benefit after all. FierceVaccines story | Follow @FiercePharma
@EricPFierce: IPCA says FDA bans will have little sales impact. Didn't Wockhardt make that claim before its profits sank? Story | Follow @EricPFierce
@CarlyHFierce: Legal fallout from Valeant's failed Allergan siege? Experts debate. Story | Follow @CarlyHFierce
> J&J CEO Gorsky sees 'new horizon' in China, despite slowing growth. More
> What does Merck's $10B buyback plan say about pharma M&A? Article
CRO News
> Recipharm pairs up with Adroit for chemistry services. Item
> Ergomed reaches into Asia on the hunt for co-development deals. Article
> BioClinica expands in NC after a string of buyouts. More
> Icon taps Carnegie Mellon to help patients better understand trials. Story
Vaccines News
> GlaxoSmithKline takes TB vaccine to Phase IIb. Item
> Emergent BioSolutions nabs government funds to test new-and-improved anthrax vaccine. News
> Chinese Ebola vaccine based on current strain looks safe in PhI. Story
> Germany's cost watchdog decides Valeant's Provenge has added benefit after all. Report
> GSK, U.K. 'hopeful' they can strike a Bexsero price deal soon. Article
Pharma Manufacturing News
> Indian state to train employees to think like FDA inspectors. Item
> San Francisco requires drugmakers to fund disposal of unused meds. News
> Tolmar adds warehouse to support new manufacturing facility. Article
> Deal done, Sun Pharma must now fix Ranbaxy's deep problems. Story
> FDA bans 2 more IPCA plants. More
Pharma Asia News
> U.S.-based Chinese researcher pleads guilty in United Imaging Healthcare bribery case. Report
> Pleasantries aside, U.S. FDA keeps sharp eye on India pharma manufacturing. Article
> Glenmark on yo-yo string sales journey with diabetes generics in U.S. More
> Actelion's PAH drug Opsumit gets Japan marketing nod, GSK's Encruse approved. Story
> Japan's MHLW approves Gilead's Sovaldi for genotype 2 chronic hep C. Article